RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com

Similar
Filing Names

Santen Pharmaceutical Co Ltd
Santen Pharmaceutical Co Ltd_20100121
  

Santen Pharmaceutical Co Ltd patents

Recent patent applications related to Santen Pharmaceutical Co Ltd. Santen Pharmaceutical Co Ltd is listed as an Agent/Assignee. Note: Santen Pharmaceutical Co Ltd may have other listings under different names/spellings. We're not affiliated with Santen Pharmaceutical Co Ltd, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Santen Pharmaceutical Co Ltd-related inventors




Date Santen Pharmaceutical Co Ltd patents (updated weekly) - BOOKMARK this page
03/23/172-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof
03/16/17Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockage
02/23/17Mtor pathway inhibitors for treating ocular disorders
01/26/17Liquid formulations for treatment of diseases or conditions
01/26/17Ophthalmic solution comprising diquafosol
11/17/16Injector for intraocular lens
11/10/16Pharmaceutical formulations comprising a pyridylaminoacetic acid compound
11/03/16Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition
11/03/16Pharmaceutical composition containing pyridylaminoacetic acid compound
10/20/16Rapamycin formulations and methods of their use
10/20/16Injectible agent and depot formation method
09/01/162-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof
08/11/16Polyethylene glycol-containing composition
08/11/16Composition for treating or preventing glaucoma comprising a sulfonamide compound and another drug
07/14/16Production 3,3-dimethyl-3,4-dihydro-1h-quinoxalin-2-one derivative and intermediate for said production method
04/21/16Ophthalmic solutions
03/31/16Sealing label with identification function and container wrapped with said sealing label
01/28/16Therapeutic agent for meibomian gland dysfunction
01/14/16Prophylactic or therapeutic agent for posterior ocular disease containing tetrahydropyranylaminocyclopentylcarbonyltetrahydropyridopyridine derivative as effective ingredient
11/19/15Intraocular lens injector
10/15/152-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof
10/01/15Intraocular lens injector
10/01/15Therapeutic or prophylactic agent for retinopathy of prematurity, testing retinopathy of prematurity, and screening therapeutic or prophylactic substance for retinopathy of prematurity
09/24/15Formulations and methods for vascular permeability-related diseases or conditions
09/03/15Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockage
07/16/15Pharmaceutical formulations comprising a pyridylaminoacetic acid compound
06/04/15Liquid formulations for treatment of diseases or conditions
05/07/15Method for changing condition of eyelid of hairless animal
05/07/15Method for changing condition of eyelid by administering complete freund's adjuvant
03/12/15Ophthalmic solution comprising diquafosol
03/12/15Composition for hair growth
01/15/15Eye drops
01/08/15Non-aqueous liquid composition
12/18/14Industrial process for preparation of 1,2-dihydroquinoline derivative or a salt thereof, and intermediate for preparation thereof
08/28/14Novel compound having parp inhibitory activity
08/07/14Ophthalmic solution comprising diquafosol, producing the same, and inhibiting formation of insoluble precipitate
07/10/14Rapamycin formulations and methods of their use
05/08/14Fixed amount discharge container
03/27/14Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol
02/13/14Method for treating an inflammatory disease by administering a 1,2,3,4-tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituent
11/21/133-hydroxy-6h-benzo [c] chromene-6-one derivative and manufacturing method thereof
10/17/13Comprehensive glaucoma determination method utilizing glaucoma diagnosis chip and deformed proteomics cluster analysis
08/29/13Drug support body, and producing same
08/01/13Liquid formulations for treatment of diseases or conditions
07/11/13Prostaglandin-containing product
07/04/13Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
05/02/13Method for treating glaucoma or ocular hypertension with an adenosine derivative
04/11/13Method for treating a trpv1-mediated disease
12/27/12Formulations and methods for vascular permeability-related diseases or conditions
12/13/12Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof
09/13/12Method for treating a keratoconjunctival disorder
08/09/12Novel thiophenediamine derivative having urea structure
08/09/12Compounds having 4-pyridylalkylthio group as a substituent
05/24/12Methods for preventing or treating metabolic diseases, inflammatory diseases, autoimmune diseases, allergic diseases, central nervous system diseases, cardiovascular diseases, homeostasis-related diseases or glaucoma
05/10/12Mtor pathway inhibitors for treating ocular disorders
05/10/122-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof
05/03/12Method for improving bioavailability of latanoprost
04/26/12Prophylactic or therapeutic agent for retinal disease and prophylaxis or therapy of retinal disease using jnk (c-jun amino-terminal kinase) - inhibitory peptide, and use of the peptide
02/16/12Therapeutic agent for glaucoma comprising rho kinase inhibitor and prostaglandin
02/09/12Transscleral delivery
12/01/11Eye drop composition containing isopropyl unoprostone
11/10/11Method for preventing or treating a disease related to the glucocorticoid receptor
11/10/11Method for preventing or treating a disease related to the glucocorticoid receptor
10/27/11Method for preventing or treating a glucocorticoid receptor-related disease
10/27/11Method for preventing or treating a disease related to the glucocorticoid receptor
Patent Packs
10/27/11Therapeutic agent for glaucoma comprising rho kinase inhibitor and ß- blocker
08/25/11Method for determination of progression risk of glaucoma
08/18/11Pharmaceutical composition improving intestinal absorption
08/11/11Composition, kit, and assaying ageing and disease accompanied with vascular disorder
07/07/11Glucocorticoid receptor agonist comprising 1,2,3,4-tetrahydroquinoxaline derivatives containing phenyl group having sulfonic acid ester structure introduced therein as substituent
06/30/11Method of treating retinal vein occlusion
06/30/11Method of treating diabetic retinopathy
05/26/11Composition, kit and assaying neuropathy
05/26/11Novel cyclic compound having pyrimidinylalkylthio group
05/26/11Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group
05/19/11Methods of stabilizing latanoprost in an aqueous solution
04/21/11Agent for enhancing corneal epithelial barrier function
03/31/11Novel thiophenediamine derivative having urea structure
03/10/11Methods for treating a skin wound
02/17/11Methods for treating a disease in which rho kinase is involved
Patent Packs
12/30/10Clear ophthalmic solution comprising latanoprost as active ingredient
12/16/10Method of enhancing ocular penetration of a drug in an eyedrop
08/05/10Method for determination of onset risk of glaucoma
06/03/10Novel 1,2,3,4,-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced terein and has glucocorticoid receptor-binding activity
04/22/10Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents
03/11/10Novel pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure
03/11/10Therapeutic agent for glaucoma comprising rho kinhase inhibitor and prostaglandin
03/04/10Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitor effect as active ingredient
02/18/10Methods for treating glaucoma
01/21/10Tnf-alpha production inhibitors
11/19/09Compounds having a 4-pyridylalkylthio group as a substituent
10/08/09Angiogenesis inhibitor containing amine derivative as active ingredient
08/06/09Method of ophthalmic surgery and kit therefor
04/30/09Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
02/05/09Noninvasive drug delivery system to tissue of posterior segment of eye using solid composition
01/21/10Tnf-alpha production inhibitors







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Santen Pharmaceutical Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Santen Pharmaceutical Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';